GS PHARMA
0848.422.277 · rovalta.com · 23/09/2026
ACTIVE
GS PHARMA
Financial year 2025 · closed on 31/12/2025
Net result
124 k €
+692.7% YoY
Gross margin
299,3 k €
+66.2% YoY
Equity
148,4 k €
+0.0% YoY
Workforce
2,0 ETP
+11.1% YoY
Overview
What does GS PHARMA do?
GS PHARMA is a Private limited company incorporated in 2012. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Dilbeek. It employs on average 2,0 ETP workers (FTE).
Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 0848.422.277
Incorporation
04/09/2012
Legal form
Private limited company
Registered office
Brusselstraat 5
1702 Dilbeek · FlandreSee on map
1702 Dilbeek · FlandreSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Average workforce
2,0 ETP
Activities (NACE)
Joint committees (1)
- 313
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Available with a Rovalta subscriptionTry for 7 days
Financials
Trend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||
| Gross margin | 299,3 k € | +66.2% | 180,1 k € | -4.9% | 189,3 k € | +3.6% | 182,8 k € | +10.8% | 164,9 k € | -2.3% | 168,8 k € | +5.9% | 159,4 k € | -28.7% | 223,5 k € | +8.8% | 205,4 k € | -14.5% | 240,4 k € | +42.4% | 168,8 k € | +16.1% | 145,3 k € | -15.6% | 172,2 k € |
| EBITDA | 158,9 k € | +193% | 54,2 k € | -18.8% | 66,7 k € | +3.9% | 64,2 k € | +12.0% | 57,3 k € | -9.3% | 63,2 k € | -17.4% | 76,5 k € | -45.6% | 140,6 k € | -0.0% | 140,7 k € | -22.7% | 182 k € | +30.0% | 140 k € | -3.4% | 145 k € | +51.5% | 95,7 k € |
| Operating result | 135 k € | +364% | 29,1 k € | -29.2% | 41,1 k € | +335% | 9,4 k € | +182% | -11,6 k € | -93.6% | -6 k € | -190% | 6,7 k € | -90.5% | 70,2 k € | -2.8% | 72,2 k € | -46.1% | 134,1 k € | +45.5% | 92,1 k € | -6.2% | 98,2 k € | +175% | 35,7 k € |
| Net result | 124 k € | +693% | 15,6 k € | -49.9% | 31,2 k € | +1239% | 2,3 k € | +111% | -21,1 k € | -40.7% | -15 k € | -502% | -2,5 k € | -104% | 57,7 k € | -10.3% | 64,4 k € | -31.6% | 94,1 k € | +47.0% | 64 k € | -16.3% | 76,5 k € | +411% | 15 k € |
| Balance sheet | |||||||||||||||||||||||||
| Equity | 148,4 k € | +0.0% | 148,4 k € | +0.4% | 147,7 k € | +16.8% | 126,5 k € | +1.9% | 124,1 k € | -14.5% | 145,3 k € | -9.4% | 160,3 k € | -1.5% | 162,8 k € | +1.7% | 160 k € | +0.2% | 159,6 k € | +67.1% | 95,5 k € | +69.0% | 56,5 k € | +61.5% | 35 k € |
| Total assets | 796,9 k € | -0.6% | 801,8 k € | +5.6% | 759,1 k € | -5.4% | 802,2 k € | +3.3% | 776,6 k € | -7.0% | 835,4 k € | +3.6% | 806,6 k € | -6.7% | 864,4 k € | -6.0% | 919,3 k € | +51.5% | 606,8 k € | +4.4% | 581,4 k € | -1.3% | 589,1 k € | -1.0% | 594,9 k € |
| Cash | 17,1 k € | -72.5% | 62,2 k € | +12.5% | 55,2 k € | -12.4% | 63,1 k € | +164% | 23,9 k € | -38.0% | 38,5 k € | +51.4% | 25,4 k € | +30.9% | 19,4 k € | -64.2% | 54,2 k € | +33.3% | 40,7 k € | +46.7% | 27,7 k € | -58.1% | 66,2 k € | +24.4% | 53,2 k € |
| Debts | 646,1 k € | -0.6% | 650 k € | +6.8% | 608,4 k € | -9.6% | 672,9 k € | +3.5% | 649,9 k € | -5.5% | 687,6 k € | +6.9% | 643 k € | -8.0% | 699,1 k € | -7.6% | 756,8 k € | +70.1% | 444,8 k € | -8.0% | 483,4 k € | -8.8% | 530,2 k € | -4.9% | 557,5 k € |
| Other | |||||||||||||||||||||||||
| Workforce | 2,0 ETP | +11.1% | 1,8 ETP | -90.0% | 18,0 ETP | +900% | 1,8 ETP | 0.0% | 1,8 ETP | -5.3% | 1,9 ETP | +18.7% | 1,6 ETP | +23.1% | 1,3 ETP | 0.0% | 1,3 ETP | +30.0% | 1,0 ETP | +150% | 0,4 ETP | – | 0,4 ETP | ||
Estimate
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
See the valuationGovernance
Board of directors
Seen on filing of 31/12/2025 · 1 active · 4 ended
Active mandates
Active
Ended mandates
Financials
Annual accounts
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 20/06/2026 | 16/10/2025 | 28/08/2024 | 26/07/2023 | 30/08/2022 | 19/08/2021 |
| General meeting | 29/05/2026 | 30/05/2025 | 31/05/2024 | 16/06/2023 | 27/05/2022 | 28/05/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Ratios
Financial ratios
Looking for more information about this company?
Try for 7 daysFilings
Annual accounts filings
13 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 29/05/2026 | 20/06/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/05/2025 | 16/10/2025 | Dutch | |
| Abridged model | 31/12/2023 | 31/05/2024 | 28/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 16/06/2023 | 26/07/2023 | Dutch | |
| Abridged model | 31/12/2021 | 27/05/2022 | 30/08/2022 | Dutch | |
| Abridged model | 31/12/2020 | 28/05/2021 | 19/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 28/08/2020 | 02/10/2020 | Dutch | |
| Abridged model | 31/12/2018 | 31/05/2019 | 19/08/2019 | Dutch | |
| Abridged model | 31/12/2017 | 15/06/2018 | 12/07/2018 | Dutch | |
| Abridged model | 31/12/2016 | 16/06/2017 | 17/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 27/05/2016 | 07/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 19/06/2015 | 13/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 20/06/2014 | 11/08/2014 | Dutch |
Valuation
Estimate
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Governance
Board of directors
Seen on filing of 31/12/2025 · 1 active · 4 ended
Active mandates
Active
Ended mandates
Shareholders
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette
Belgian Official Gazette publications
Source: Belgian Official Gazette
Similar companies
Competition
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025124 k €↑
- 2024Annual accounts 202415,6 k €↓
- 2023Annual accounts 202331,2 k €↑
- 2022Annual accounts 20222,3 k €↑
- 2021Annual accounts 2021-21,1 k €↓
- 2020Annual accounts 2020-15 k €↓
- 2019Annual accounts 2019-2,5 k €↓
- 2018Annual accounts 201857,7 k €↓
- 2017Annual accounts 201764,4 k €↓
- 2016Annual accounts 201694,1 k €↑
- 2015Annual accounts 201564 k €↓
- 2014Annual accounts 201476,5 k €↑
- 2013Annual accounts 201315 k €
- 04/09/2012IncorporationPrivate limited company